Published in

Elsevier, The Lancet, 10267(396), p. 1979-1993, 2020

DOI: 10.1016/s0140-6736(20)32466-1

Links

Tools

Export citation

Search in Google Scholar

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Journal article published in 2020 by Maheshi N. Ramasamy, Angela M. Minassian ORCID, Katie J. Ewer, Amy L. Flaxman, Pedro M. Folegatti ORCID, Daniel R. Owens, Merryn Voysey, Parvinder K. Aley, Brian Angus, Sofiyah Fedosyuk, Gavin Babbage, Sandra Belij-Rammerstorfer, Sagida Bibi, Lisa Berry, Mustapha Bittaye and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO